MedTrace Logo

Evaluation of Immunobiogram® as a Tool in Adjustment of Immunosuppressant Therapy for Renal Transplant

NCT03562845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 164

Last updated 2023-12-29

No results posted yet for this study

Summary

The trial is an observational, multi-center study to determine if a new blood test (Immunobiogram®) done after renal transplant can help predict how well the immune system is working and responding to a new kidney. These blood tests could, in the future, potentially guide how doctors manage patient's anti-rejection medication.

Conditions

  • Kidney Transplantation

Interventions

OTHER

NA-Observational only

NA-Observational only

Sponsors & Collaborators

  • Biohope Scientific Solutions for Human Health, S.L.

    lead INDUSTRY

Principal Investigators

  • Julio Pascual, MD, PhD · Parc du Salut Mar

Eligibility

Min Age
25 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-04-30
Completion
2019-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03562845 on ClinicalTrials.gov